Table 2. Profile of hypertensive patients at the start of the Pharmaceutical Care.
Sociodemographic Profile | Cardiovascular Risk Profile | ||||||
---|---|---|---|---|---|---|---|
n (104) | % | n (104) | % | ||||
Sex | Obesity*(BMI ≥30 Kg/m2) | Yes | 56 | 53,9 | |||
Male | 26 | 25,0 | No | 48 | 46,2 | ||
Female | 78 | 75,0 | |||||
Age | |||||||
30–40 years | 2 | 1,9 | Dyslipidemia | Yes | 28 | 26,9 | |
41–59 years | 35 | 33,7 | No | 76 | 73,1 | ||
>60 years | 67 | 64,4 | |||||
Skin Color | |||||||
White | 58 | 55,8 | Family History | Yes | 14 | 13,5 | |
Black | 8 | 7,7 | No | 90 | 86,5 | ||
Mixed | 38 | 36,5 | |||||
Education | |||||||
Iliterate | 8 | 7,7 | Smoking | Yes | 5 | 4,8 | |
Primary Education | 75 | 72,1 | No | 99 | 95,2 | ||
High School | 17 | 16,3 | |||||
University | 4 | 3,9 | |||||
Ocupational Activity | 71 | 68,3 | Diabetes | Yes | 19 | 18,3 | |
Family Income | No | 85 | 81,7 | ||||
up to 1 MW | 7 | 6,7 | |||||
>1–2 MW | 26 | 25,0 | |||||
>2–3 MW | 29 | 27,9 | Waist Circumference* | Changed | 84 | 80,8 | |
>3–5 MW | 32 | 30,8 | Not Changed | 20 | 19,2 | ||
>5 MW | 10 | 9,6 |
* Source: VI Brazilian Guidelines on Hypertension (2010); BMI = Body Mass Index; Changed waist circumference values greater than 102 cm for men and 88 cm for women were considered; MW = Minimum Wage, household income was classified according to Brazilian Institute of Geography and Statistics—IBGE.